About Melt Pharmaceuticals
Melt Pharmaceuticals is a company based in United States founded in 2018 was acquired by Harrow in September 2025.. Melt Pharmaceuticals has raised $77.29 million across 3 funding rounds from investors including Harrow. Melt Pharmaceuticals offers products and services including MELT-300 and Combination Drug Formulations.
- Headquarter United States
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Melt Pharmaceuticals, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Melt Pharmaceuticals
Melt Pharmaceuticals offers a comprehensive portfolio of products and services, including MELT-300 and Combination Drug Formulations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A sublingual tablet is developed for needle- and opioid-free procedural sedation and analgesia in short-duration medical procedures
Non-intravenous and non-opioid sedation formulations are created to address sedation needs in outpatient settings
Funding Insights of Melt Pharmaceuticals
Melt Pharmaceuticals has successfully raised a total of $77.29M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $24.0M
-
First Round
First Round
(05 Feb 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series B - Melt Pharmaceuticals | Valuation |
investors |
|
| Jul, 2023 | Amount | Series B - Melt Pharmaceuticals | Valuation |
investors |
|
| Feb, 2019 | Amount | Series A - Melt Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Melt Pharmaceuticals
Melt Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Harrow. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ophthalmic products marketing services are provided by Harrow.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Melt Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Melt Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Melt Pharmaceuticals Comparisons
Competitors of Melt Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Melt Pharmaceuticals
When was Melt Pharmaceuticals founded?
Melt Pharmaceuticals was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Melt Pharmaceuticals located?
Melt Pharmaceuticals is headquartered in United States.
Is Melt Pharmaceuticals a funded company?
Melt Pharmaceuticals is a funded company, having raised a total of $77.29M across 3 funding rounds to date. The company's 1st funding round was a Series A of $11M, raised on Feb 05, 2019.
What does Melt Pharmaceuticals do?
Melt Pharmaceuticals was founded in 2018 and is headquartered in the United States. Operations are centered in the pharmaceutical sector, though specific services and products remain undisclosed in available records. The companys domain, meltpharma.com, serves as its online presence. Limited public data exists on detailed activities, with focus inferred on drug development or related innovations typical to the industry.
What products or services does Melt Pharmaceuticals offer?
Melt Pharmaceuticals offers MELT-300 and Combination Drug Formulations.
Who are Melt Pharmaceuticals's investors?
Melt Pharmaceuticals has 1 investor. Key investors include Harrow.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.